Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study

Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study

Item
http://www.wikidata.org/entity/Q57484919

Low doses vs. high doses of the angiotensin converting-enzyme inhibitor lisinopril in chronic heart failure: a cost-effectiveness analysis based on the Assessment of Treatment with Lisinopril and Survival (ATLAS) study

Item
http://www.wikidata.org/entity/Q57484919
description
article
@en
im Dezember 2000 veröffentlichter wissenschaftlicher Artikel
@de
wetenschappelijk artikel
@nl
наукова стаття, опублікована в грудні 2000
@uk
name
Low doses vs. high doses of th ...... ril and Survival (ATLAS) study
@en
Low doses vs. high doses of th ...... t with Lisinopril and Survival
@nl
type
label
Low doses vs. high doses of th ...... ril and Survival (ATLAS) study
@en
Low doses vs. high doses of th ...... t with Lisinopril and Survival
@nl
prefLabel
Low doses vs. high doses of th ...... ril and Survival (ATLAS) study
@en
Low doses vs. high doses of th ...... t with Lisinopril and Survival
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P433
P478
P50
P577
P698
P356
P1433
P1476
Low doses vs. high doses of th ...... ) study. The ATLAS Study Group
@en
P2093
P2860
P304
P31
P356
10.1016/S1388-9842(00)00122-7
P433
P478
P50
P577
P698